779 related articles for article (PubMed ID: 23935243)
21. Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response.
Arjuman A; Chandra NC
Diab Vasc Dis Res; 2013 Sep; 10(5):442-51. PubMed ID: 23811604
[TBL] [Abstract][Full Text] [Related]
22. OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.
Ryoo S; Bhunia A; Chang F; Shoukas A; Berkowitz DE; Romer LH
Atherosclerosis; 2011 Feb; 214(2):279-87. PubMed ID: 21130456
[TBL] [Abstract][Full Text] [Related]
23. Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway.
Ou HC; Chou WC; Hung CH; Chu PM; Hsieh PL; Chan SH; Tsai KL
Environ Toxicol; 2019 Jul; 34(7):825-835. PubMed ID: 30963716
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36.
Crucet M; Wüst SJ; Spielmann P; Lüscher TF; Wenger RH; Matter CM
Atherosclerosis; 2013 Jul; 229(1):110-7. PubMed ID: 23706521
[TBL] [Abstract][Full Text] [Related]
25. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease.
Dunn S; Vohra RS; Murphy JE; Homer-Vanniasinkam S; Walker JH; Ponnambalam S
Biochem J; 2008 Jan; 409(2):349-55. PubMed ID: 18092947
[TBL] [Abstract][Full Text] [Related]
26. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
Reiss AB; Anwar K; Wirkowski P
Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
[TBL] [Abstract][Full Text] [Related]
27. Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1.
Chen KC; Hsieh IC; Hsi E; Wang YS; Dai CY; Chou WW; Juo SH
J Cell Sci; 2011 Dec; 124(Pt 23):4115-24. PubMed ID: 22135361
[TBL] [Abstract][Full Text] [Related]
28. The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions.
Lund AK; Lucero J; Harman M; Madden MC; McDonald JD; Seagrave JC; Campen MJ
Am J Respir Crit Care Med; 2011 Jul; 184(1):82-91. PubMed ID: 21493736
[TBL] [Abstract][Full Text] [Related]
29. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
Morawietz H
Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
[TBL] [Abstract][Full Text] [Related]
30. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo.
Akhmedov A; Rozenberg I; Paneni F; Camici GG; Shi Y; Doerries C; Sledzinska A; Mocharla P; Breitenstein A; Lohmann C; Stein S; von Lukowicz T; Kurrer MO; Borén J; Becher B; Tanner FC; Landmesser U; Matter CM; Lüscher TF
Eur Heart J; 2014 Oct; 35(40):2839-48. PubMed ID: 24419805
[TBL] [Abstract][Full Text] [Related]
31. The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells.
Li L; Renier G
Atherosclerosis; 2009 May; 204(1):40-6. PubMed ID: 18801483
[TBL] [Abstract][Full Text] [Related]
32. Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis.
Syväranta S; Alanne-Kinnunen M; Oörni K; Oksjoki R; Kupari M; Kovanen PT; Helske-Suihko S
Atherosclerosis; 2014 Aug; 235(2):398-407. PubMed ID: 24929820
[TBL] [Abstract][Full Text] [Related]
33. ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production.
Mattaliano MD; Wooters J; Shih HH; Paulsen JE
Am J Physiol Cell Physiol; 2010 May; 298(5):C1180-7. PubMed ID: 20181930
[TBL] [Abstract][Full Text] [Related]
34. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.
Lu J; Yang JH; Burns AR; Chen HH; Tang D; Walterscheid JP; Suzuki S; Yang CY; Sawamura T; Chen CH
Circ Res; 2009 Mar; 104(5):619-27. PubMed ID: 19150883
[TBL] [Abstract][Full Text] [Related]
35. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis.
Kume N; Kita T
Trends Cardiovasc Med; 2001 Jan; 11(1):22-5. PubMed ID: 11413048
[TBL] [Abstract][Full Text] [Related]
36. Oxidized LDL, LOX-1 and atherosclerosis.
Mitra S; Goyal T; Mehta JL
Cardiovasc Drugs Ther; 2011 Oct; 25(5):419-29. PubMed ID: 21947818
[TBL] [Abstract][Full Text] [Related]
37. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.
Zeya B; Arjuman A; Chandra NC
Biochemistry; 2016 Aug; 55(32):4437-44. PubMed ID: 27419271
[TBL] [Abstract][Full Text] [Related]
38. Oxidized LDL and LOX-1 in experimental sepsis.
Al-Banna N; Lehmann C
Mediators Inflamm; 2013; 2013():761789. PubMed ID: 24000272
[TBL] [Abstract][Full Text] [Related]
39. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells.
Aoyama T; Fujiwara H; Masaki T; Sawamura T
J Mol Cell Cardiol; 1999 Dec; 31(12):2101-14. PubMed ID: 10640439
[TBL] [Abstract][Full Text] [Related]
40. LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma.
Schaeffer DF; Riazy M; Parhar KS; Chen JH; Duronio V; Sawamura T; Steinbrecher UP
J Lipid Res; 2009 Aug; 50(8):1676-84. PubMed ID: 19359704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
